Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis.
about
Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapyReview article: the management of autoimmune hepatitis beyond consensus guidelinesNon-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.Budesonide induces complete remission in autoimmune hepatitisA budesonide prodrug accelerates treatment of colitis in rats.Safety of inhaled corticosteroids in children.Autoimmune hepatitis: focusing on treatments other than steroids.Oxymetazoline hydrochloride combined with mometasone nasal spray for persistent nasal congestion (pilot study)Current and future treatments of autoimmune hepatitis.Advances in the current treatment of autoimmune hepatitis.Drug choices in autoimmune hepatitis: part A--Steroids.Management of allergic rhinitis: focus on intranasal agents.Biotransformation in vitro of the 22R and 22S epimers of budesonide by human liver, bronchus, colonic mucosa and skin.Comparison of inhaled corticosteroids.Pharmacology of nasal medications: an update.Macrophages on the nasal mucosal surface in provoked and naturally occurring allergic rhinitis.Differences in inhaled fluticasone bioavailability between holding chambers in children with asthma.Intratracheal budesonide-poly(lactide-co-glycolide) microparticles reduce oxidative stress, VEGF expression, and vascular leakage in a benzo(a)pyrene-fed mouse model.Review article: issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease.A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis.
P2860
Q26853649-F6256FAB-FE4E-406E-AB97-CFA7F4ABC744Q26864272-855EE403-E4EB-4A36-A57A-4A5F8F9F64ACQ33447479-07E9F001-FD60-4F6A-8305-78C96A184B11Q34012678-B0D172DE-5CE9-413C-85D3-E3EBF1DC4A40Q34379809-5A71F3F5-D8A6-444A-8A1F-2B2CEE26EFF5Q34523194-3AA7D788-A059-41E7-AE77-8256E03E9F8EQ36231841-9CA32B5A-E9FD-4FA6-9832-5A87B93EDA60Q36834694-9F79E440-1FD6-4FB4-8CC8-A66B23AE8760Q37503380-D052945B-C7A2-490C-A529-0420942C3BC7Q38000056-3A519B79-4601-4418-87DB-FAD944350BFEQ38051705-094DD2BA-EE90-433C-B754-6213689CFCA2Q38372205-ED905B10-127B-49E2-B83D-141F5726CB48Q40790551-4218DF20-B295-48BA-973E-5506F2774CC1Q41718750-8B44037B-F0D5-41C4-8F71-F1BD7E6C34FCQ42981419-C06B89A3-BB4A-481F-8ED0-E8273744CAADQ44022896-A6C026E9-59E9-4A1E-B132-F05007C68365Q44098848-759D7C98-A775-4A52-9BCC-AA68AD83D588Q46207350-0A171C56-AD71-40EF-9D5E-704066C8041CQ46859854-127FCB6A-EB41-4432-A633-8B972B1CD70AQ54068366-C6AE6CEB-1085-4A0C-A068-E48BDE85EFF7
P2860
Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Budesonide. A preliminary revi ...... ficacy in asthma and rhinitis.
@en
type
label
Budesonide. A preliminary revi ...... ficacy in asthma and rhinitis.
@en
prefLabel
Budesonide. A preliminary revi ...... ficacy in asthma and rhinitis.
@en
P1433
P1476
Budesonide. A preliminary revi ...... ficacy in asthma and rhinitis.
@en
P2093
S P Clissold
P304
P356
10.2165/00003495-198428060-00001
P577
1984-12-01T00:00:00Z
P6179
1018880049